{"id":792568,"date":"2024-12-04T18:35:58","date_gmt":"2024-12-04T23:35:58","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/"},"modified":"2024-12-04T18:35:58","modified_gmt":"2024-12-04T23:35:58","slug":"insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/","title":{"rendered":"Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court<\/b><\/p>\n<p class=\"bwalignc\"><b>Jury awards $452M in damages<\/b><\/p>\n<p>ACTON, Mass.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nInsulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.omnipod.com%2F&amp;esheet=54162106&amp;newsitemid=20241204689248&amp;lan=en-US&amp;anchor=tubeless+insulin+pump&amp;index=1&amp;md5=70d1164a989a2dadb688a686f81c1599\">tubeless insulin pump<\/a> technology with its Omnipod<sup>\u00ae<\/sup> brand of products, announced that it has successfully defended its intellectual property against EOFlow Co., Ltd. (\u201cEOFlow&#8221;) in federal court.<\/p>\n<p>\nAfter a four-week trial in the U.S. District Court for the District of Massachusetts in the matter of Insulet Corporation vs. EOFlow et al., a jury verdict was returned in favor of Insulet on December 3, 2024.<\/p>\n<p>\nThe jury found that EOFlow and several other defendants misappropriated Insulet\u2019s trade secrets. The jury awarded the Company $170 million in compensatory damages from EOFlow and an additional $282 million in exemplary damages from EOFlow for willful and malicious misappropriation, for a total damages award of $452 million. EOFlow\u2019s ability to satisfy this damage award is not known with certainty.<\/p>\n<p>\n&#8220;We are extremely pleased with the jury\u2019s verdict, which validates our commitment to protecting our technology and defending our intellectual property against misappropriation and infringement,&#8221; said Jim Hollingshead, Insulet President and Chief Executive Officer. &#8220;We will not only enforce our patents, but also zealously protect our valuable trade secrets, in which we\u2019ve invested heavily to improve the lives of people with diabetes.&#8221;<\/p>\n<p><b><i>About Insulet Corporation:<\/i><\/b><\/p>\n<p>\nInsulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet\u2019s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.insulet.com&amp;esheet=54162106&amp;newsitemid=20241204689248&amp;lan=en-US&amp;anchor=insulet.com&amp;index=2&amp;md5=226563d54f586f33b6d3bba083187328\">insulet.com<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fomnipod.com&amp;esheet=54162106&amp;newsitemid=20241204689248&amp;lan=en-US&amp;anchor=omnipod.com&amp;index=3&amp;md5=7f80bc0ed8561fd8eaf43104acccbcfb\">omnipod.com<\/a>.<\/p>\n<p>\n\u00a92024 Insulet Corporation. Omnipod is a registered trademark of Insulet Corporation. All rights reserved. All other trademarks are the property of their respective owners.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241204689248r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20241204689248\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20241204689248\/en\/<\/a><\/span><\/p>\n<p><b><i>Investor Relations:<br \/>\n<\/i><\/b><br \/>June Lazaroff<br \/>\n<br \/>Senior Director, Investor Relations<br \/>\n<br \/>(978) 600-7718<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:jlazaroff@insulet.com\">jlazaroff@insulet.com<br \/>\n<\/a><\/p>\n<p><b><i>Media:<br \/>\n<\/i><\/b><br \/>Angela Geryak Wiczek<br \/>\n<br \/>Senior Director, Corporate Communications<br \/>\n<br \/>(978) 932-0611<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:awiczek@insulet.com\">awiczek@insulet.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Massachusetts United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Technology Men Medical Devices LGBTQ+ Science Family Consumer Health Research Other Technology Other Consumer Teens Women Parenting Seniors Children Religion<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20241204689248\/en\/1711909\/3\/INSULET_Logo_RGB_No_tag.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court Jury awards $452M in damages ACTON, Mass.&#8211;(BUSINESS WIRE)&#8211; Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod\u00ae brand of products, announced that it has successfully defended its intellectual property against EOFlow Co., Ltd. (\u201cEOFlow&#8221;) in federal court. After a four-week trial in the U.S. District Court for the District of Massachusetts in the matter of Insulet Corporation vs. EOFlow et al., a jury verdict was returned in favor of Insulet on December 3, 2024. The jury found that EOFlow and several other defendants misappropriated Insulet\u2019s trade secrets. The jury awarded the Company $170 million in compensatory damages &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-792568","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court Jury awards $452M in damages ACTON, Mass.&#8211;(BUSINESS WIRE)&#8211; Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod\u00ae brand of products, announced that it has successfully defended its intellectual property against EOFlow Co., Ltd. (\u201cEOFlow&#8221;) in federal court. After a four-week trial in the U.S. District Court for the District of Massachusetts in the matter of Insulet Corporation vs. EOFlow et al., a jury verdict was returned in favor of Insulet on December 3, 2024. The jury found that EOFlow and several other defendants misappropriated Insulet\u2019s trade secrets. The jury awarded the Company $170 million in compensatory damages &hellip; Continue reading &quot;Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-04T23:35:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241204689248r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court\",\"datePublished\":\"2024-12-04T23:35:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\\\/\"},\"wordCount\":481,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20241204689248r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\\\/\",\"name\":\"Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20241204689248r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2024-12-04T23:35:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20241204689248r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20241204689248r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/","og_locale":"en_US","og_type":"article","og_title":"Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court - Market Newsdesk","og_description":"Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court Jury awards $452M in damages ACTON, Mass.&#8211;(BUSINESS WIRE)&#8211; Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod\u00ae brand of products, announced that it has successfully defended its intellectual property against EOFlow Co., Ltd. (\u201cEOFlow&#8221;) in federal court. After a four-week trial in the U.S. District Court for the District of Massachusetts in the matter of Insulet Corporation vs. EOFlow et al., a jury verdict was returned in favor of Insulet on December 3, 2024. The jury found that EOFlow and several other defendants misappropriated Insulet\u2019s trade secrets. The jury awarded the Company $170 million in compensatory damages &hellip; Continue reading \"Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-04T23:35:58+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241204689248r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court","datePublished":"2024-12-04T23:35:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/"},"wordCount":481,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241204689248r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/","name":"Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241204689248r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2024-12-04T23:35:58+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241204689248r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241204689248r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-successfully-defends-its-intellectual-property-against-eoflow-co-in-u-s-district-court\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/792568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=792568"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/792568\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=792568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=792568"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=792568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}